Travere Therapeutics Announces Planned Retirement of Chief Research Officer in 2027
Go back to Travere Therapeutics Announces Planned Retirement of Chief Research Officer in 2027| (NASDAQ: TVTX) | Delayed: 64.74 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $64.74 | 52 Week High | $ | |||
| Open | $64.74 | 52 Week Low | $ | |||
| Day High | $64.74 | P/E | N/A | |||
| Day Low | $64.74 | EPS | $ | |||
| Volume | 28,307 | |||||

